Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Life Technologies sells majority share in mass spectrometry business

Life Technologies sells majority share in mass spectrometry business

3rd September 2009

Life Technologies has signed a contract to sell the controlling stake of its mass spectrometry arm to Danaher for a total of $450 million (276 million pounds), it has revealed.

Previously operated jointly, the business will now be owned by Danaher, which has also revealed that it has acquired Life Technologies’ partner firm MDS Analytical Technologies – a division of MDS.

All transactions are anticipated to be completed by the final financial quarter of 2009.

Greg Lucier, chairman and chief executive of Life Technologies, stated that the sale of the mass spectrometry arm will allow the firm to shift its focus to its core capabilities.

He added: "By concentrating on biological solutions that leverage our expertise in DNA, RNA, proteins and cells, we will continue to drive breakthroughs in life science research, genomic medicine, molecular diagnostics and applied markets."

In other Life Technologies news, the company announced early in August that it had completed the sale of its SQL*LIMS business arm to Labvantage Solutions, but did not disclose a sum. ADNFCR-1050-ID-19344712-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.